[null, {"document_url": "https://lifescienceleadermag.epubxp.com/i/503574-cro-supplement-2015/51", "unformatted_src": "https://content.cdntwrk.com/files/aT01MDM1NzQmcD01MSZ2PTEmY21kPXYmc2lnPWYzNjkxNzM2ZmZlODk3MzE4MDZlNjExMmM3MzIzYTE0/-w-450-80.jpg", "src": "https://content.cdntwrk.com/files/aT01MDM1NzQmcD01MSZ2PTEmY21kPXYmc2lnPWYzNjkxNzM2ZmZlODk3MzE4MDZlNjExMmM3MzIzYTE0/-w-450-80.jpg"}, null]
Page 51 of 51

THE SOUND OF STRONGER SCIENCE HAS ARRIVED. More solutions, more insights and more synergy. That's the idea behind our new union: building on our combined strengths to drive innovation and improve outcomes for our clients. Going forward, LabCorp Clinical Trials and Covance will operate together under the Covance brand. We bring our clients unmatched drug development solutions, industry leading laboratory science and faster, new approaches for patient recruitment. Together , we create stronger solutions in perfect harmony. LEARN MORE ABOUT OUR UNION: The Americas +1.888.COVANCE | Europe/Africa +00.800.2682.2682 Asia Pacific +800.6568.3000 | Or go to covance.com Covance Inc., headquartered in Princeton, NJ, is the drug development business of Laboratory Corporation of America ® Holdings (LabCorp ® ). Covance is the marketing name for Covance Inc. and its subsidiaries around the world. © Copyright 2015 . Covance Inc.



